Home

Colleges

Quick Links

Resources

Campus

Administration

Community

Bios

Benjamin Malcolm, PharmD, MPH, BCPP

Assistant Professor

College of Pharmacy

E-Mail: bmalcolm@westernu.edu

Phone: 8582

Education

PGY2 Psychiatric Pharmacy Residency 2016 University of California at San Diego

PGY1 Pharmacy Practice Residency 2015 Scripps Mercy Hospital, San Diego, CA

PharmD 2014 Touro University, CA

MPH 2014 Touro University, CA

BS Pharmacology 2008 University of California at Santa Barbara

Education Experience

As a newly minted academician, Dr. Malcolm’s current teaching responsibilities include coordination of the clinical portion of the psychiatric pharmacy curriculum.

Teaching Experience

Dr. Malcolm’s current teaching responsibilities include coordination of the clinical portion of the psychiatric pharmacy curriculum. He also offers an elective course in essential oil ethnobotany, pharmacology, and application.

Research Interest

Drug-assisted psychotherapy is an emerging field that combines elements of traditional psychotherapy with novel psychoactive compounds to address mental health disease states that are refractory to standard treatments. Dr. Malcolm hopes to explore this field as part of his research endeavors.

Awards

Service Excellence Award, Touro University College of Pharmacy May 2014 USPHS Excellence in Public Health Pharmacy Practice Award March 2014 Phi Lambda Sigma National Chapter of the Year Award March 2013 Student of the Year Award, Touro University College of Pharmacy May 2011

Organizations

College of Psychiatric and Neurologic Pharmacists (CPNP)

California Society of Health Systems Pharmacists (CSHP)

Publications

Barsuglia JP, Polanco M, Palmer R, Malcolm BJ, Kelmendi B, Calvey T. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder. Progress in Brain Research, Available online 25 October 2018. https://doi.org/10.1016/bs.pbr.2018.08.002

Malcolm BJ(PRO); Murphy L; Wong M (CON). Should Medical Cannabis Administered by Inhalation Be Allowed for Hospitalized Patients?. The Canadian Journal of Hospital Pharmacy, [S.l.], v. 71, n. 3, june 2018. ISSN 1920-290

Malcolm BJ, Polanco M, Barsuglia J. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine. J Psychoactive Drugs. 2018 Apr 2:1-10. doi: 10.1080/02791072.2018.1447175.

Malcolm B, Tallian K. Essential oil of lavender in anxiety disorders: Ready for prime time? Mental Health Clinician: July 2017, Vol. 7, No. 4, pp. 147-155.

Feifel D, Malcolm B, Boggie D, Lee K. Low-dose ketamine for treatment resistant depression in an academic clinical practice setting. Journal of Affective Disorders 2017;221:283-8.

Thomas K, Malcolm BJ, Lastra D (2017). Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders. J Psychoactive Drugs: 1-10.

Malcolm BJ, Lee KC. Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness? Mental Health Clinician: January 2017, Vol. 7, No. 1, pp. 39-45.

Malcolm BJ, Perry P, Yoshizuka K. Marijuana and Pharmacy Practice: A Call to Action. California Journal of Health-Systems Pharmacy. 2014 Sep-Oct. Vol. 26 No. 5.

Chou T, Lash DB, Malcolm BJ, Yousify L, Dong S, Quach J, Yu J. Effects of a Student Pharmacist Consultation on Vaccine Knowledge & Attitudes. Journal of the American Pharmacists Association. 2014 Mar-Apr;54(2):130-7. doi: 10.1331/JAPhA.2014.13114